TITLE

Use of SSRIs during pregnancy

PUB. DATE
November 2009
SOURCE
Internal Medicine Alert;Nov2009 Pharmacology Watch Supp, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that mothers taking selective serotonin reuptake inhibitors (SRRIs) during pregnancy increase the risk of septal heart defects in their children.
ACCESSION #
46778054

 

Related Articles

  • Use of SSRIs during pregnancy. Elliott, William T. // Primary Care Reports;Nov2009 Pharmacology Watch, p1 

    The article discusses the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy. It explains that SSRIs are associated with septal heart defects, which pregnant women can obtain through taking sertraline and citalopram based on a study from Denmark. The highlight of the...

  • SSRI use in pregnancy not linked to cardiac malformations in infants.  // Reactions Weekly;6/22/2013, Issue 1458, p1 

    The article discusses a British pharmacoepidemiological study indicating that the use of selective serotonin reuptake inhibitors (SSRI) in early pregnancy was not associated with cardiac malformations or septal defects in offspring.

  • SSRIs Associated With Low Rate of Birth Defects, Studies Show. Elliott, William T. // Clinical Cardiology Alert;Aug2007 Pharmacology Watch, p1 

    The article reports on two studies in the "New England Journal of Medicine" which revealed the association of selective serotonin reuptake inhibitors (SSRIs) with a low rate of birth defects. Researchers from Boston University and Harvard found that the use of SSRIs was not associated with...

  • Use of SSRIs during pregnancy.  // Travel Medicine Advisor;Nov2009 Supplement, p1 

    The article focuses on a study from Denmark which reveals that use of selective serotonin reuptake inhibitors (SSRIs) such as sertraline and citalopram during pregnancy results to higher risk of septal heart defects in children. It states that the research was based from the Danish nationwide...

  • Study finds link between SSRIs and congenital heart defects.  // Reactions Weekly;10/3/2009, Issue 1272, p1 

    The article discusses research in the U.S. and Denmark on the association of selective serotonin reuptake inhibitor (SSRI) with the prevalence of congenital heart defects. It references a study by C. Chamber, published in the September 2009 issue of the "British Medical Journal." In the first...

  • Selective serotonin reuptake inhibitors and congenital malformations. Chambers, Christina // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/26/2009, Vol. 339 Issue 7723, p703 

    The author discusses the findings of a study conducted in Denmark in 2009 which demonstrated the link between early exposure to selective serotonin reuptake inhibitors (SSRI) and increased risk for septal heart defects. The author ponders on how the findings may aid in clinicians' and patients'...

  • Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. Pedersen, Lars Henning; Henriksen, Tine Brink; Vestergaard, Mogens; Olsen, Jørn; Bech, Bodil Hammer // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/26/2009, Vol. 339 Issue 7723, p735 

    The article discusses a cohort study on the relationship between selective serotonin reuptake inhibitors (SSRI) administered during pregnancy and congenital major malformations. The study was done among children born in Denmark from 1996 to 2003. Findings demonstrated an increased incidence of...

  • SSRIs are not major teratogens when taken in first trimester.  // Contemporary OB/GYN;Aug2007, Vol. 52 Issue 8, p12 

    The article offers information on two studies about the association between selective serotonin reuptake inhibitors (SSRI) and risks of birth defects. In their study, Carol Louik and colleagues found no significant increases in the risks of craniosynostosis, omphalocele, or heart defects...

  • SSRIs and Pregnancy: Increase in Septal Heart Defects. Elliott, William T. // Clinical Cardiology Alert;Nov2009 Pharmacology Watch, p1 

    The article discusses a new study from Denmark which included that selective serotonin reuptake inhibitors (SSRIs) increase risk of septal heart defects in children. According to the study of almost 500,000 births from 1996 to 2003, pregnant women who took sertraline and citalopram were more...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics